Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
This study is currently recruiting participants.
Study NCT00290823 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: February 9, 2006 Last Updated: September 25, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurocysticercosis
Additional conditions recognized in this trial
Cysticercosis
Taeniasis
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Helminthiasis
Central Nervous System Infections
Central Nervous System Parasitic Infections
Cestode Infections
Helminthiasis
Nervous System Diseases
Parasitic Diseases
Interventions listed in this trial
Albendazole
Dexamethasone
Omeprazole
Additional drug interventions recognized in this trial
Dexamethasone acetate
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Ulcer Agents
Anticestodal Agents
Antiemetics
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Autonomic Agents
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content
